Creating a new immunotherapy approach to fight aggressive medulloblastoma
Finding a way to use immunotherapy against a high-risk type of childhood brain tumour.
Investigating clinical trial samples to predict how atypical teratoid rhabdoid tumours will respond to treatment
Looking at cancer samples to find markers that can predict how a child's cancer will respond to treatment.
Confirming bloodstream markers of children’s kidney cancer
Identifying markers that can be used for a non-invasive test to diagnose and monitor Wilms tumour.
How does teenage and young adult cancer treatment affect the risk of kidney disease?
This project aims to find out more about kidney damage in teenagers and young adults who have been treated for cancer. Dr Nicola Hughes wants to know what puts young people with cancer at risk of kidney damage, and to create helpful information for patients and their families.
What are young people and their families’ experiences of melanoma?
This project will investigate how young people and their families experience skin cancer. Dr Wendy McInally hopes to further develop the teenage and young adult cancer service, and create information that will help young people with skin cancer and their families.
Blocking chemical reactions which keep ependymoma cells alive
Testing four medicines to see if they can shut down the metabolism of brain cancer cells grown in the lab
Stopping drug resistant processes in T-cell acute lymphoblastic leukaemia
Developing a test to select patients who can be treated with a new medicine that prevents steroid resistance.
Repurposing alcohol-abuse medicines to treat brain tumours
Understanding how a repurposed drug attacks and kills diffuse midline glioma cells.
Blocking processes which keep leukaemia cells alive
Investigating the possibility of combining a medicine that blocks the process with a medicine that triggers a cell's defensive response to treat ALL.